Authors: Kate E. Mason*, Gillian Maudsley, Philip McHale, Andy Pennington, Jennifer Day and Ben Barr Objectives: Early in the COVID-19 pandemic, people with underlying comorbidities were overrepresented in hospitalised cases of COVID-19, but the relationship between comorbidity […]
The Age-Related Risk of Severe Outcomes Due to COVID-19 Infection: A Rapid Review, Meta-Analysis, and Meta-Regression
Authors: Karla Romero Starke 1, Gabriela Petereit-Haack 2, Melanie Schubert 1, Daniel Kämpf 1, Alexandra Schliebner 1, Janice Hegewald 1, Andreas Seidler 1 Abstract Increased age appears to be a strong risk factor for COVID-19 severe outcomes. However, studies do not sufficiently consider […]
Potential for False Positive Results with Antigen Tests for Rapid Detection of SARS-CoV-2 – Letter to Clinical Laboratory Staff and Health Care Providers
Authors: FDA The U.S. Food and Drug Administration (FDA) is alerting clinical laboratory staff and health care providers that false positive results can occur with antigen tests, including when users […]
Antigen and Molecular Tests
Diagnostic tests are used to detect current, active infections of the SARS-CoV-2 virus. Diagnostic tests can be antigen based (“rapid antigen” tests), which look for protein markers on the outside of […]
Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses
Authors: Ian W. Pray, PhD1,2,3,*; Laura Ford, PhD1,2,*; Devlin Cole, MD3,4; Christine Lee, PhD1,5; John Paul Bigouette, PhD1,2; Glen R. Abedi, MPH1; Dena Bushman, MSN, MPH1,2; Miranda J. Delahoy, PhD1,2; […]
Interim Guidance for Antigen Testing for SARS-CoV-2
Authors: CDC Summary of Recent Changes Updates as of May 13, 2021 Updated guidance based on new published studies on antigen test performance. Clarification about which NAATs should be used […]
Scientists explain possible causes of anaphylaxis following mRNA COVID-19 vaccination
Authors: By Angela Betsaida B. Laguipo, BSN In an effort to stem the spread of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) […]
Anaphylaxis is a rare reaction in COVID-19 vaccination
Authors: R G Bellomo 1, C E Gallenga 2, Al Caraffa 3, G Tetè 4, G Ronconi 5, P Conti 6 Abstract Anaphylaxis is a severe multisystem reaction that occurs rapidly after the introduction of an antigen that would otherwise be […]
Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination
Authors: CDC Summary of recent changes (last updated March 3, 2021) Considerations broadened to include use of Janssen (Johnson & Johnson) COVID-19 vaccine. Key Points Under the Emergency Use Authorizationsexternal icon for […]
FDA Authorizes Covid Booster Shots For Immunocompromised Patients
Authors: BY TYLER DURDEN After growing chatter over the past week, late on Thursday the U.S. Food and Drug Administration authorized booster shots for certain people with weakened immune systems, […]